Latest Equity Placements News

Lithium Plus Minerals has significantly upgraded its Lei Lithium Project resource and secured a 20-year mining lease, positioning the company for near-term development and commercialisation.

Vanadium Resources (ASX: VR8) has locked in a right of first refusal and exclusivity option over a prime brownfield site in South Africa’s Highveld Industrial Park for its planned V-Iron Plant, reinforcing its path towards feasibility and financing.

ClearVue Technologies saw a 35% revenue decline to $161,000 and a $11 million net loss in FY2026, driven by a major operational overhaul and significant product certification efforts. Despite the financial setback, the company expanded into new markets and secured key commercial projects.

Orbital Corporation has broadened its customer base and product lineup, positioning itself to capture growth in defence and commercial UAV markets with $3.2 million in expected sales for Q1 FY2027.

Provaris Energy reported a $4.045 million loss for FY2026 as it progressed proprietary hydrogen and liquid CO₂ storage technologies, expanded strategic partnerships, and boosted cash reserves through multiple placements.

Cambium Bio has secured FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development costs and timelines. Despite a AUD 4.1 million loss for FY2026, the company strengthened its funding position and manufacturing partnerships ahead of patient dosing targeted for late 2026.

Austral Resources Australia Ltd has swung from a $24.2 million loss to a $25.3 million profit in the first half of 2026, boosted by strategic acquisitions, capital raises, and operational shifts. The company is advancing its Rocklands restart and has proposed acquiring Hammer Metals to expand its copper footprint.

Spacetalk Ltd reported a 17% revenue decline in FY26 amid a strategic reset, but mobile revenue grew 16% as the company pivots to a software-led family safety platform supported by new telco partnerships.

FireFly Metals has raised approximately A$190 million through institutional and bought deal placements, positioning the company to advance its Green Bay Copper-Gold Project with early works, drilling, and feasibility studies ahead of a mid-2027 investment decision.

COG Financial Services lifted revenue 10% to $403.4 million and net profit after tax attributable to members by 29% to $24.24 million for FY26, driven by a 51% jump in its Salary Packaging segment including the Easifleet acquisition. The company declared a fully franked 7.0 cents per share dividend, suspending its dividend reinvestment plan.

Neurizon Therapeutics has completed enrolment in its pivotal HEALEY ALS Platform Trial ahead of schedule, secured critical manufacturing and funding agreements, and reduced its net loss for FY2026 while preparing for topline results in late Q2 2027.

Viridis Mining and Minerals completes a Definitive Feasibility Study for its Colossus Rare Earth Project, confirming strong economics and project readiness, while securing $120 million in equity funding to advance into execution.